Stock Events

Stock Events

AdvisorShares Psychedelics 

$20.47
69
+$0.13+0.64% Today

Statistics

Day High
20.55
Day Low
20.15
52W High
21.61
52W Low
11.16
Volume
228,702
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
9.24%
Dividend
1.89

Upcoming

23
JUN
Dividend Ex
Estimated
 
26
JUN
Dividend Payment
Estimated
 
22
SEP
Dividend Ex
Estimated
 
29
SEP
Dividend Payment
Estimated
 
22
DEC
Dividend Ex
Estimated
 
29
DEC
Dividend Payment
Estimated
 

Expense Ratio

0.99%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

9.24%Dividend Yield
Dec 25
$1.68
Sep 25
$0.02
Jun 25
$0.01
Mar 25
$0.16
Dec 24
$0.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
282.43%
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PSIL. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.22B
COMPASS Pathways focuses on psilocybin therapy for mental health, aligning with PSIL's investment in psychedelic therapeutics.
AtaiBeckley
ATAI
Mkt Cap1.52B
ATAI Life Sciences is a biotech company with a focus on psychedelic and non-psychedelic compounds for mental health, similar to PSIL's focus.
GH Research
GHRS
Mkt Cap1.42B
GH Research is developing a novel therapeutic approach using 5-MeO-DMT, competing in the same space as PSIL's interests.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, competing with PSIL's psychedelic medicine investments.
Revive Therapeutics
RVVTF
Mkt Cap11.33M
Revive Therapeutics is exploring the use of psychedelics in treatments, which places it in direct competition with PSIL's market.

Holdings

Regions

Sectors

About

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
Show more...
CEO
Country
United States
ISIN
US00768Y2972

Listings

ARCX
US
PSIL
BOATS
BOATS
PSIL.BOATS

0 Comments

Share your thoughts

FAQ

What is AdvisorShares Psychedelics stock price today?▼
The current price of PSIL is $20.47 USD — it has increased by +0.64% in the past 24 hours. Watch AdvisorShares Psychedelics stock price performance more closely on the chart.
What is AdvisorShares Psychedelics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange AdvisorShares Psychedelics stocks are traded under the ticker PSIL.
Is AdvisorShares Psychedelics stock price growing?▼
PSIL stock has risen by +6.07% compared to the previous week, the month change is a +16.54% rise, over the last year AdvisorShares Psychedelics has showed a +83.15% increase.
Does AdvisorShares Psychedelics pay dividends?▼
Yes, PSIL dividends are paid quarterly. The last dividend per share was 1.68 USD. As of today, Dividend Yield (FWD)% is 9.24%.
In which sector is AdvisorShares Psychedelics located?▼
AdvisorShares Psychedelics operates in the Other sector.
When did AdvisorShares Psychedelics complete a stock split?▼
The last stock split for AdvisorShares Psychedelics was on September 10, 2024 with a ratio of 1:10.